Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001274225-04-000003
Filing Date
2004-05-03
Accepted
2004-05-03 16:07:04
Documents
2
Period of Report
2004-05-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1443
2 EDGAR SUPPORTING DOCUMENT poa-langer.txt EX-24 3100
  Complete submission text file 0001274225-04-000003.txt   6535
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O TRANSKARYOTIC THERAPIES INC 700 MAIN STREET CAMBRIDGE MA 02139
Business Address C/O TRANSKARYOTIC THERAPIES INC 700 MAIN STREET CAMBRIDGE MA 02139 6173490200
LANGER DENNIS (Reporting) CIK: 0001274225 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 04773758